ALIGN TECHNOLOGY INC (ALGN)
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for ALGN
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| ALGN | Chair of Compensation and Human Capital Committee | 60 | ["CEO and Chairman of the Board at Exact Sciences Corp. (2014-2026)","President and CEO at Third Wave Technologies, Inc. (2005-2008)","General Counsel at Third Wave Technologies, Inc. (2004-2005)","Various Leadership Positions at GE Healthcare","Extensive experience in healthcare and molecular diagnostics industries"] | ["Compensation and Human Capital Committee"] | 2026 |
Companies shown below are based on exact name match for the selected Director
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| EXAS | President, CEO and Chairman of the Board of Directors, Exact Sciences Corporation; Chairman, President and Chief Executive Officer | 54 | ["Extensive business, legal and executive leadership experience", "Significant knowledge of the healthcare industry", "Experience in the molecular diagnostics industry"] | [] | 2020 |
Biography sourced from the proxy statement filing.
Age: 60 Director Since: 2023 Roles: Independent Director; Chair of Compensation and Human Capital Committee Committees: Compensation and Human Capital Committee Election Term: 2026-2027 Experience: 2009 - 2026 CEO and Chairman of the Board (2014), Exact Sciences Corp. (molecular diagnostics company) 2005 - 2008 President and CEO, Third Wave Technologies, Inc. (molecular diagnostics company) 2004 - 2005 General Counsel, Third Wave Technologies, Inc. (molecular diagnostics company) Prior Various Leadership Positions at GE Healthcare (medical technology company) Other Board Positions Exact Sciences Corp. (2014-2026) Fuze Health (2025-present) Adaptive Biotechnologies Corporation (2019-2023) Epizyme, Inc. (2017-2022) CM Life Sciences II Inc. (2021) SomaLogic, Inc. (2021) Arya Sciences Acquisition Corp. (2018-2020) Notable Experience and Key Board Contributions Mr. Conroy has extensive experience creating stockholder value as a business, legal, corporate strategy, and executive leader and has significant experience in the healthcare and the molecular diagnostics industries. At Exact Sciences, Mr. Conroy helped to develop Cologuard and the company has grown to $2.76B in revenue while serving 4.5 million patients. At Third Wave, Mr. Conroy developed and brought a novel cervical cancer screening test, Cervista, to patients. Education B.S. in Electrical Engineering from Michigan State University J.D. from the University of Michigan Law School